Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age-Reference-Cited by-同舟云学术

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age

Published:2016-04 Issue:4 Volume:35 Page:e113-e123
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Snape Matthew D.,Voysey Merryn,Finn Adam,Bona Gianni,Esposito Susanna,Principi Nicola,Diez-Domingo Javier,Sokal Etienne,Kieninger Dorothee,Prymula Roman,Dull Peter M.,Kohl Igor,Barone Michelangelo,Wang Huajun,Toneatto Daniela,Pollard Andrew J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference17 articles.

1. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom.;Auckland;J Infect Dis,2006

2. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.;Galloway;Int J Epidemiol,2009

3. Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.;Jackson;Arch Dis Child,2011

4. Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.;Holst;Vaccine,2003

5. European MenB Vaccine Study Group. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.;Gossger;JAMA,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review;Human Vaccines & Immunotherapeutics;2024-09-12

2. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles;Microbial Pathogenesis;2023-12

3. Meningococcal Vaccines Directed at Capsular Group B;Plotkin's Vaccines;2023

4. Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage;Expert Review of Vaccines;2022-06-03

5. Invasive serogroup B meningococci in England following three years of 4CMenB vaccination – First real-world data;Journal of Infection;2021-11